Prof. Mercè Brunet, Hospital Clinic of Barcelona, Spain
Professor Brunet received her PD from the University of Barcelona, Spain in 1980 and got her PhD in Pharmacology at University of Barcelona in 1993.
Professor Brunet is currently Head of Pharmacology and Toxicology Unit, Service of Biochemistry and Molecular Biology at the Hospital Clínic of Barcelona.
Professor Brunet has been a Councilor of the Steering Committee of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) and is now Secretary of the Catalonian Society of Transplantation, and has served on many Committees for the American Transplant Congress and the National Research Nets of Health.
Professor’s Brunet research interests are centered on the measurement of biomarkers that may reflect immunosuppressive drugs’ exposure and effect, using pharmacokinetic, pharmacogenetic and pharmacodynamic approaches, as well as PK/PD immunosuppression clinical trial designs. She is the leader of the Biomarker Working Group of the Scientific Committee of Immunosuppressive Drugs of the IATDMCT. Dr Brunet’s main research interest includes the development of novel translational, diagnostic, and pharmacokinetic/ pharmacodynamics monitoring strategies of antitumor and antiretroviral drugs.